查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1970926

門診心電圖（ECG）市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Ambulatory Electrocardiography ECG Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球攜帶式心電圖 (ECG) 市場預計將從 2025 年的 5.6545 億美元成長到 2031 年的 8.6732 億美元，複合年成長率為 7.39%。

在這個領域，諸如心電圖監測和攜帶式遙測系統等攜帶式設備被用於持續監測心臟的電活動，使患者能夠繼續日常生活。推動該市場發展的關鍵因素包括全球心血管疾病和心房顫動發生率的上升，以及人口老化對頻繁心臟監測的需求。此外，醫療保健系統向遠端患者監護的策略轉變，旨在減少住院治療，也進一步推動了對這些診斷設備的需求成長。

市場概覽
預測期 2027-2031
市場規模：2025年 5.6545億美元
市場規模：2031年 8.6732億美元
複合年成長率：2026-2031年 7.39%
成長最快的細分市場 可攜式的
最大的市場 北美洲

然而，市場成長面臨許多重大障礙，包括複雜的報銷通訊協定和資料管理難題，阻礙了小規模醫療機構的採用。根據歐洲心臟學會2024年的數據，成員國每年將有超過300萬人死於心血管疾病。雖然這項數據凸顯了普及診斷工具的迫切性，但資金限制和監管複雜性仍然是市場廣泛採用的障礙。

市場促進因素

心血管疾病和心律不整發生率的上升是全球攜帶式心電圖（ECG）市場的主要驅動力。隨著心臟病在全球範圍內的影響日益加劇，醫療系統越來越重視能夠早期發現和治療心房顫動及其他傳導障礙的連續性、非侵入性監測方法。這項關鍵的臨床需求源自於這些疾病死亡率的上升。根據世界衛生組織（WHO）2025年7月發布的心血管疾病（CVD）的說明書，預計2022年全球將有1,980萬人死於心血管疾病，約佔全球死亡總數的32%。因此，隨著醫療服務提供者努力在標準醫院環境之外進行及時診斷以改善患者預後，對心電圖監測和行動遙測系統等攜帶式監測設備的需求激增。

推動市場成長的第二個關鍵因素是技術突破以及人工智慧 (AI) 在穿戴式裝置中的應用。這些創新正迅速改變產業格局，從笨重的有線記錄器轉向配備 AI 演算法的隱藏式貼片感測器，用於即時檢測心律不整和抑制噪音。例如，根據 2025 年 7 月出版的《心血管商業》雜誌報道，美國食品藥物管理局(FDA)核准了Cardiosense 公司的 CardioTag，這是一款新型穿戴式感測器，能夠同時記錄心電圖 (ECG) 和其他生理指標，以評估心臟功能。此類技術進步正帶來顯著的商業性成功和廣泛的應用。根據 iRhythm Technologies 公司於 2025 年 2 月發布的“2024 年第四季度及全年財務業績報告”，該公司年收入成長 20.1%，達到 5.918 億美元，主要得益於其 Zio攜帶式監測服務的使用量增加。

市場挑戰

複雜的報銷系統和資料管理難題是攜帶式心電圖市場擴張的主要障礙。醫療機構，尤其是小規模獨立診所，在取得長期監測服務費用所需的行政工作中經常遇到困難。複雜的編碼結構和不一致的保險覆蓋標準導致收入不確定性，使得醫療機構不願投資先進的行動遙測系統。此外，持續監測產生的大量數據需要大規模的儲存和處理能力，這給缺乏先進資訊技術基礎設施的機構帶來了額外的經濟負擔。

這些營運障礙有效地限制了向大型醫院網路提供服務，阻礙了市場擴張。當診所無法有效處理診斷數據或保證報銷時，它們開立門診監測處方的可能性就會降低，從而限制了市場規模。鑑於需要治療的患者數量龐大，這瓶頸尤為嚴重。根據美國心臟協會預測，到2024年，約有48.6%的美國成年人將受到心血管疾病的影響。這一數字凸顯了數據管理挑戰的嚴峻性，因為心臟病的廣泛流行需要可擴展的基礎設施，而許多醫療機構目前由於監管和經濟方面的限制而無法做到這一點。

市場趨勢

消費級穿戴裝置與臨床級心電圖 (ECG) 技術的整合正在改變患者照護路徑，使廣泛普及的裝置也能實現醫療級心律不整檢測。製造商們正不斷獲得監管部門的核准，推出多感測器設備，使患者能夠在家中記錄單導聯心電圖，從而減少對醫療機構診斷的依賴。這項進步將臨床層級的精準度帶入日常生活，有效彌合生活方式追蹤與專業醫療監測之間的差距，支持對諸如心房顫動等疾病的早期治療。根據 Femtech Insider 2025 年 11 月發表的題為「Withings BeamO 獲得 FDA 批准」的報導，Withings 的 BeamO 獲得了 FDA 批准。 BeamO 是一款多功能設備，整合了心電圖和其他感測器，可在不到一分鐘的時間內完成詳細的健康核准。

同時，用於即時監測的行動心電遙測（MCT）技術的普及，正在為需要長期觀察的高風險患者建立新的治療標準。與傳統的心電圖監測不同，這種方法能夠自動將異常心律資料傳輸到中央監測中心，從而最大限度地減少診斷和治療的延遲。這種向互聯互通和即時臨床可視性的轉變，正在顯著提升領先醫療技術公司的收入，這些公司正不斷拓展其診斷產品組合。根據波士頓科學公司於2025年2月發布的2024會計年度年度報告，該公司實現了167億美元的年度淨銷售額，年增17.6%。這主要得益於全球需求的成長以及心臟病學領域的創新進步。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：血管心電圖（ECG）市場的全球展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（攜帶式、補丁式、其他）
    • 透過應用（醫院、動態心電圖服務提供者、家庭護理機構等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美門診心電圖（ECG）市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲門診心電圖（ECG）市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區門診心電圖（ECG）市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲門診心電圖（ECG）市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲門診心電圖（ECG）市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球動態心電圖（ECG）市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • Koninklijke Philips NV
  • Cardinal Health, Inc.
  • Cardiac Insight, Inc.
  • Bionet America, Inc.
  • Bardy Diagnostics, Inc.
  • EDAN Instruments, Inc.
  • Powerful Medical Inc.
  • HeartBeam, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27576

The Global Ambulatory Electrocardiography ECG Market is projected to expand from USD 565.45 Million in 2025 to USD 867.32 Million by 2031, reflecting a compound annual growth rate of 7.39%. This sector involves the continuous tracking of cardiac electrical activity using portable instruments, such as Holter monitors or mobile telemetry systems, allowing patients to continue their everyday activities. The primary forces propelling this market include the rising global rates of cardiovascular disorders and atrial fibrillation, coupled with an aging population necessitating frequent cardiac surveillance. Furthermore, the strategic transition of healthcare frameworks toward remote patient monitoring to decrease hospital admissions bolsters the growing demand for these diagnostic instruments.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 565.45 Million
Market Size 2031USD 867.32 Million
CAGR 2026-20317.39%
Fastest Growing SegmentPortable
Largest MarketNorth America

However, market growth confronts significant hurdles related to intricate reimbursement protocols and data management difficulties, which hinder adoption in smaller healthcare institutions. Data from the European Society of Cardiology in 2024 indicates that cardiovascular disease is responsible for over 3 million annual deaths across its member nations. While this statistic underscores the urgent need for accessible diagnostic tools, financial limitations and regulatory complexities persist as barriers preventing widespread market saturation.

Market Driver

The increasing incidence of cardiovascular diseases and arrhythmias serves as the primary engine driving the Global Ambulatory Electrocardiography ECG Market. With the global impact of heart conditions growing heavier, healthcare systems are placing greater emphasis on continuous, non-invasive monitoring options to enable the early identification and treatment of atrial fibrillation and other conduction issues. This critical clinical need is supported by the elevated mortality rates linked to these ailments. According to the World Health Organization's 'Cardiovascular diseases (CVDs)' fact sheet from July 2025, cardiovascular diseases resulted in an estimated 19.8 million deaths worldwide in 2022, accounting for roughly 32% of global fatalities. Consequently, requests for ambulatory tools like Holter monitors and mobile telemetry systems have escalated as providers aim to improve patient outcomes via timely diagnostics outside standard hospital environments.

The second pivotal factor stimulating market growth involves technological breakthroughs in wearable devices and the incorporation of artificial intelligence. These innovations are swiftly moving the industry away from bulky wired recorders toward unobtrusive, patch-based sensors featuring AI algorithms designed for real-time arrhythmia detection and noise suppression. For example, Cardiovascular Business reported in July 2025 that the U.S. FDA cleared Cardiosense's CardioTag, a new wearable sensor capable of simultaneously recording electrocardiogram (ECG) and other physiological metrics to assess cardiac function. Such technological advancements are resulting in substantial commercial success and uptake. As noted in iRhythm Technologies' 'Fourth Quarter and Full Year 2024 Financial Results' from February 2025, the company achieved a 20.1% rise in annual revenue to $591.8 million, largely attributed to higher volumes of its Zio ambulatory monitoring services.

Market Challenge

Complicated reimbursement frameworks and data management difficulties function as major impediments to the expansion of the ambulatory electrocardiography market. Healthcare providers, especially smaller independent practices, frequently encounter difficulties with the administrative tasks necessary to obtain payment for long-term monitoring services. The complexity of coding structures and inconsistent coverage standards introduce revenue uncertainty, causing facilities to hesitate before investing in advanced mobile telemetry systems. Additionally, the massive amount of data produced by continuous monitoring necessitates significant storage and processing power, placing extra financial pressure on institutions that lack sophisticated information technology infrastructure.

These operational obstacles restrict market reach by effectively limiting services to major hospital networks. When clinics are unable to efficiently handle diagnostic data or ensure reimbursement, their likelihood of prescribing ambulatory monitoring decreases, which in turn stifles market volume. This bottleneck is particularly critical given the vast number of patients needing attention. According to the American Heart Association, cardiovascular disease impacted roughly 48.6 percent of the adult population in the United States in 2024. This figure highlights the enormity of the data management issue, as the widespread prevalence of cardiac conditions demands a scalable infrastructure that many facilities currently cannot support due to regulatory and economic constraints.

Market Trends

The merging of consumer wearables with clinical-grade ECG technology is transforming patient care pathways by making medical-grade arrhythmia detection possible through widely available devices. Manufacturers are frequently securing regulatory clearances for multi-sensor instruments that enable patients to record single-lead ECGs at home, thereby lessening the reliance on facility-based diagnostics. This development supports earlier treatment for issues such as atrial fibrillation by bringing clinical accuracy into everyday life, effectively closing the divide between lifestyle tracking and professional medical oversight. As reported by Femtech Insider in November 2025, within the article 'Withings Receives FDA Clearance for BeamO,' Withings obtained FDA approval for its BeamO device, a multiscope integrating an electrocardiogram with other sensors to conduct thorough health assessments in less than one minute.

Simultaneously, the widespread adoption of Mobile Cardiac Telemetry (MCT) for real-time monitoring is establishing a new standard of care for high-risk patients needing prolonged observation. This method differs from conventional Holter monitors by automatically sending abnormal rhythm data to centralized monitoring hubs, which minimizes the delay in diagnosis and treatment. This transition toward connectivity and instant clinical visibility is fueling substantial revenue increases for leading medical technology companies expanding their diagnostic portfolios. According to Boston Scientific's '2024 Annual Report' released in February 2025, the company achieved full-year net sales of $16.7 billion, a 17.6 percent rise, largely propelled by robust global demand and innovative progress within its cardiology divisions.

Key Market Players

  • GE HealthCare Technologies Inc.
  • Hill-Rom Holdings, Inc.
  • Koninklijke Philips N.V.
  • Cardinal Health, Inc.
  • Cardiac Insight, Inc.
  • Bionet America, Inc.
  • Bardy Diagnostics, Inc.
  • EDAN Instruments, Inc.
  • Powerful Medical Inc.
  • HeartBeam, Inc.

Report Scope

In this report, the Global Ambulatory Electrocardiography ECG Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ambulatory Electrocardiography ECG Market, By Type

  • Portable
  • Patch
  • Others

Ambulatory Electrocardiography ECG Market, By Application

  • Hospital
  • Holter Service Provider
  • Home
  • Others

Ambulatory Electrocardiography ECG Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ambulatory Electrocardiography ECG Market.

Available Customizations:

Global Ambulatory Electrocardiography ECG Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ambulatory Electrocardiography ECG Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Portable, Patch, Others)
    • 5.2.2. By Application (Hospital, Holter Service Provider, Home, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Ambulatory Electrocardiography ECG Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ambulatory Electrocardiography ECG Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Ambulatory Electrocardiography ECG Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Ambulatory Electrocardiography ECG Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Ambulatory Electrocardiography ECG Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. France Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Ambulatory Electrocardiography ECG Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia Pacific Ambulatory Electrocardiography ECG Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Ambulatory Electrocardiography ECG Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. Middle East & Africa Ambulatory Electrocardiography ECG Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ambulatory Electrocardiography ECG Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Ambulatory Electrocardiography ECG Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Ambulatory Electrocardiography ECG Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. South America Ambulatory Electrocardiography ECG Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ambulatory Electrocardiography ECG Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Ambulatory Electrocardiography ECG Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Ambulatory Electrocardiography ECG Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ambulatory Electrocardiography ECG Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. GE HealthCare Technologies Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hill-Rom Holdings, Inc.
  • 15.3. Koninklijke Philips N.V.
  • 15.4. Cardinal Health, Inc.
  • 15.5. Cardiac Insight, Inc.
  • 15.6. Bionet America, Inc.
  • 15.7. Bardy Diagnostics, Inc.
  • 15.8. EDAN Instruments, Inc.
  • 15.9. Powerful Medical Inc.
  • 15.10. HeartBeam, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer